Group One Trading’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$58.9M Sell
4,782,700
-1,866,600
-28% -$23.4M 0.08% 210
2026
Q2
$98.1M Sell
6,649,300
-2,005,800
-23% -$13.8M 0.14% 135
2026
Q1
$36.6M Sell
8,655,100
-2,551,500
-23% -$11.4M 0.07% 270
2025
Q4
$42.2M Buy
11,206,600
+1,692,000
+18% +$3.29M 0.07% 250
2025
Q3
$15.3M Buy
9,514,600
+5,506,600
+137% +$9.8M 0.03% 641
2025
Q2
$8.78M Buy
4,008,000
+1,938,100
+94% +$2.97M 0.02% 905
2025
Q1
$2.24M Sell
2,069,900
-174,300
-8% -$207K 0.01% 1725
2024
Q4
$2.33M Buy
2,244,200
+367,400
+20% +$419K 0.01% 1784
2024
Q3
$2.35M Sell
1,876,800
-661,500
-26% -$808K 0.01% 1602
2024
Q2
$3.02M Buy
2,538,300
+1,816,200
+252% +$2.47M 0.01% 1134
2024
Q1
$729K Buy
722,100
+630,200
+686% +$529K ﹤0.01% 2374
2023
Q4
$97.4K Sell
91,900
-202,400
-69% -$219K ﹤0.01% 4492
2023
Q3
$483K Buy
294,300
+139,300
+90% +$220K ﹤0.01% 2945
2023
Q2
$243K Sell
155,000
-50,900
-25% -$81.8K ﹤0.01% 3738
2023
Q1
$294K Buy
205,900
+85,200
+71% +$211K ﹤0.01% 3302
2022
Q4
$285K Buy
120,700
+8,800
+8% +$24.7K ﹤0.01% 3539
2022
Q3
$226K Sell
111,900
-4,100
-4% -$11.3K ﹤0.01% 4019
2022
Q2
$259K Buy
116,000
+37,600
+48% +$110K ﹤0.01% 4046
2022
Q1
$524K Buy
78,400
+63,100
+412% +$369K ﹤0.01% 3765
2021
Q4
$85K Sell
15,300
-6,200
-29% -$46.9K ﹤0.01% 5874
2021
Q3
$197K Sell
21,500
-40,900
-66% -$379K ﹤0.01% 5189
2021
Q2
$693K Buy
62,400
+49,600
+388% +$484K ﹤0.01% 3854
2021
Q1
$109K Buy
12,800
+11,900
+1,322% +$97.4K ﹤0.01% 5580
2020
Q4
$5K Buy
+900
New +$3.6K ﹤0.01% 6036
2019
Q1
– Sell
-1,154
Closed -$71K – 5322
2018
Q4
$71K Hold
1,154
– – ﹤0.01% 3373
2018
Q3
$70K Hold
1,154
– – ﹤0.01% 3769
2018
Q2
$197K Buy
1,154
+116
+11% +$31.8K ﹤0.01% 3062
2018
Q1
$179K Buy
1,038
+443
+74% +$126K ﹤0.01% 2871
2017
Q4
$234K Hold
595
– – ﹤0.01% 2824
2017
Q3
$315K Buy
595
+2
+0.3% +$1.32K ﹤0.01% 2426
2017
Q2
$517K Sell
593
-8
-1% -$6.96K 0.01% 1945
2017
Q1
$550K Sell
601
-1,870
-76% -$3.1M 0.01% 1789
2016
Q4
$7.19M Buy
+2,471
New +$14.4M 0.07% 311

Other funds holding SLS

Group One Trading's SLS Position: Q3 2026 in Review

Group One Trading opened a new position in SELLAS Life Sciences (SLS) in Q3 2026: 684,301 shares worth $8.42M. The stake represents 0.01% of the portfolio and ranks #1052 among its holdings. This is a return to the name: Group One Trading previously reported a position in SLS as recently as Q4 2023.

Group One Trading first reported a position in SLS in Q4 2016 and has held it in 18 quarters since. 218 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Group One Trading held 684,301 shares of SELLAS Life Sciences worth $8.42M as of Q3 2026.
  • SELLAS Life Sciences was a new Group One Trading position in Q3 2026.
  • SELLAS Life Sciences made up 0.01% of Group One Trading's portfolio in Q3 2026, its #1052 holding.
  • Group One Trading first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 18 quarters since.
  • 218 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.